Safety and Efficacy of RPh201 in Patients with Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Update Item Information
Identifier 20180306_nanos_posters_147
Title Safety and Efficacy of RPh201 in Patients with Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Creator Leonard A. Levin; Eitan Rath; Zvi Segal; Konstantin Adamsky; Zadik Hazan
Affiliation (LAL) McGill University, Montreal, QC, Canada; (ER) (ZS) Galilee Medical Center, Nahariya, Israel; (KA) (ZH) Regenera Pharma, Ness Ziona, Israel
Subject Optic Neuropathy
Description No proven treatment for nonarteritic anterior ischemic optic neuropathy (NAION) exists, in the acute or late phase. Preclinical data with RPh201, a novel botanical drug, suggest it may have neuroprotective and neuroenhancing effects.
Date 2018-03
Language eng
Format application/pdf
Type Text
Source 2018 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2018: Poster Presentations
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2018. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6vf0zp9
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 1309568
Reference URL https://collections.lib.utah.edu/ark:/87278/s6vf0zp9
Back to Search Results